STTK · Shattuck Labs, Inc.

$7.22 -0.15 (-2.04%)

Market Cap

$565.14M

76.68M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-06-10	Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
2026-06-09	Shattuck Labs, Inc. Announces Proposed Public Offering
2026-06-09	Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
2026-06-08	Shattuck Labs Announces Phase 1 Results for SL-325
2026-06-05	Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
2026-05-07	Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
2026-03-05	Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
2026-02-25	Shattuck Labs Announces Participation in Upcoming March Investor Conferences
2026-02-06	Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
2025-12-15	Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Past events

Date	Event	Type
2026-06-08	Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update	Event
2026-03-02	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-12	Piper Sandler Virtual Novel Targets in Immunology Symposium	Event
2025-10-08	Wedbush Securities Key Opinion Leader (KOL) and Company Panel	Event
2025-04-09	24th Annual Needham Healthcare Conference	Conference
2025-02-20	European Crohn’s and Colitis Organization (ECCO) Presentation	Presentation
2025-02-08	2025 Crohn’s and Colitis Congress	Event
2025-01-16	43rd Annual J.P. Morgan Healthcare Conference	Conference
2024-12-04	7th Annual Evercore ISI HealthCONx Conference	Conference
2024-12-03	Piper Sandler 36th Annual Healthcare Conference	Conference
2024-10-01	Company Update and Announcement of SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist	Event
2024-08-05	BTIG Virtual Biotechnology Conference	Conference
2024-06-14	Shattuck Labs EHA 2024 Conference Call	Conference
2024-04-17	Citi's Biotech C-Suite Fireside Chat Series	Event
2024-04-08	23rd Annual Needham Healthcare Conference	Conference
2024-03-04	TD Cowen 44th Annual Health Care Conference	Conference
2024-01-11	42nd Annual J.P. Morgan Healthcare Conference	Conference
2023-12-13	Shattuck Labs ASH 2023 Conference Call	Conference
2023-11-29	6th Annual Evercore ISI HealthCONx Conference	Conference
2023-11-09	Shattuck Labs Q3 2023 Earnings Call	Earnings call
2023-04-19	22nd Annual Needham Virtual Healthcare Conference	Conference
2023-03-13	Oppenheimer 33rd Annual Healthcare Conference	Conference
2023-03-06	Cowen 43rd Annual Health Care Conference	Conference
2023-02-23	Shattuck Labs Q4 2022 Earnings Call	Earnings call
2023-01-12	JP Morgan 41st Annual Healthcare Conference	Conference

Source: https://ir.shattucklabs.com/overview/default.aspx

Key facts CIK 1680367 CUSIP 82024L103 13F (30d) 19 filings 19 filers Visit website Investor relations